| BOC Sciences | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (631) 485-4226 | |||
![]() |
info@bocsci.com | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2010 | ||||
| Chengdu Biopurify Phytochemicals Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (28) 8263-3860 8263-3987 | |||
![]() |
sales@biopurify.com biopurify@gmail.com | |||
![]() |
Skype Chat | |||
![]() |
QQ chat | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2017 | ||||
| Cfm Oskar Tropitzsch GmbH | Germany | Inquire | ||
|---|---|---|---|---|
![]() |
+49 (9231) 9619-0 | |||
![]() |
info@cfmot.de | |||
| Chemical distributor since 1985 | ||||
| chemBlink standard supplier since 2022 | ||||
| Yunnan Hande Bio-tech Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 18187887160 | |||
![]() |
marketing@handebio.com | |||
| Chemical manufacturer since 1983 | ||||
| chemBlink standard supplier since 2022 | ||||
| LKT Laboratories, Inc. | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (888) 558-5227 | |||
![]() |
peacerli@mbolin-lktlabs.com | |||
| Chemical manufacturer | ||||
| BioVectra, Inc. | Canada | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (902) 566-9116 (866) 883-2872 | |||
![]() |
info@biovectra.com | |||
| Chemical manufacturer since 1970 | ||||
| Ivy Fine Chemicals | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (856) 465-8550 | |||
![]() |
sales@ivychem.com | |||
| Chemical manufacturer | ||||
| Classification | Biochemical >> Chinese herbal medicine ingredients |
|---|---|
| Name | 13-Acetyl-9-dihydrobaccatin III |
| Synonyms | 2a,3,4,4a,5,6,9,10,12,12a-Decahydro-4a,8,13,13-tetramethyl-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxete-4,5,6,9,11,12,12b-heptol (2aR,4S,4aS,5R,6R,9S,11S,12S,12aR,12bS)-6,9,12b-triacetate 12-benzoate |
| Molecular Structure | ![]() |
| Molecular Formula | C33H42O12 |
| Molecular Weight | 630.69 |
| CAS Registry Number | 142203-65-4 |
| Market Analysis Reports |
| List of Reports Available for 13-Acetyl-9-dihydrobaccatin III |